Evidence map›Paper›PMID 29108236›Full record

ArticleOncotarget2017

The autophagic inhibition oral squamous cell carcinoma cancer growth of 16-hydroxy-cleroda-3,14-dine-15,16-olide.

Ming-Fang Cheng, Shian-Ren Lin, Fong-Jen Tseng, Yi-Chao Huang, May-Jywan Tsai, Yaw-Syan Fu, Ching-Feng Weng

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Clerodane Diterpenoids from an Edible PlantMolecules (Basel, Switzerland) · 2021
    Article
  4. Phytochemicals fromMolecules (Basel, Switzerland) · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Ming-Fang ChengDepartment of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Shian-Ren LinDepartment of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien, Taiwan.
Fong-Jen TsengDepartment of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien, Taiwan.
Yi-Chao HuangTaoyuan Armed Forces General Hospital, Taoyuan, Taiwan.
May-Jywan TsaiNeural Regeneration Laboratory, Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
Yaw-Syan FuDepartment of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan.
Ching-Feng WengDepartment of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien, Taiwan.
National Dong Hwa University · TWHualien Armed Forces General Hospital · TWKaohsiung Medical University · TWNational Defense Medical Center · TWTaipei Veterans General Hospital · TWTaoyuan Armed Forces General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

16-hydroxycleroda-3, 13-dine-15, 16-olide (HCD) isolated from

Indexed as

16-hydroxy-cleroda-3,14-dine-15,16-olideautophagylong-leaf polyalthiaoral squamous carcinomaxenograft tumor

Identifiers

PMID29108236
PMCPMC5667969
OpenAlexW2731680621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.